NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $57,769 | -29.8% | 82,603 | +126.5% | 0.00% | – |
| Q4 2022 | $82,257 | -29.8% | 36,475 | -50.0% | 0.00% | – |
| Q3 2022 | $117,117 | -15.1% | 72,952 | +100.4% | 0.00% | – |
| Q2 2022 | $138,000 | -29.6% | 36,406 | -0.1% | 0.00% | – |
| Q1 2022 | $196,000 | -62.2% | 36,452 | -4.9% | 0.00% | – |
| Q4 2021 | $518,000 | +7.5% | 38,331 | +42.7% | 0.00% | – |
| Q3 2021 | $482,000 | -59.0% | 26,869 | -54.3% | 0.00% | -100.0% |
| Q1 2021 | $1,177,000 | +42.3% | 58,826 | +18.0% | 0.00% | – |
| Q3 2020 | $827,000 | -43.9% | 49,839 | -21.7% | 0.00% | -100.0% |
| Q2 2020 | $1,475,000 | +21.5% | 63,683 | -6.4% | 0.00% | 0.0% |
| Q1 2020 | $1,214,000 | -95.1% | 68,012 | -94.0% | 0.00% | -92.3% |
| Q4 2019 | $24,548,000 | -7.6% | 1,137,287 | -22.0% | 0.01% | -7.1% |
| Q3 2019 | $26,560,000 | -69.5% | 1,458,153 | -40.4% | 0.01% | -70.2% |
| Q2 2019 | $87,039,000 | +5.2% | 2,446,263 | -0.7% | 0.05% | +2.2% |
| Q1 2019 | $82,752,000 | -0.4% | 2,462,860 | -2.5% | 0.05% | -13.2% |
| Q4 2018 | $83,061,000 | -70.0% | 2,526,961 | -44.3% | 0.05% | -64.2% |
| Q3 2018 | $276,514,000 | +15.7% | 4,535,998 | -7.4% | 0.15% | +8.8% |
| Q2 2018 | $239,070,000 | -57.4% | 4,895,968 | -7.3% | 0.14% | -58.9% |
| Q1 2018 | $561,119,000 | +146.9% | 5,282,811 | +38.8% | 0.33% | +136.4% |
| Q4 2017 | $227,253,000 | +184.4% | 3,805,314 | +14.3% | 0.14% | +174.5% |
| Q3 2017 | $79,903,000 | +130.5% | 3,329,281 | +87.8% | 0.05% | +112.5% |
| Q2 2017 | $34,661,000 | – | 1,772,929 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |